IREHF Stock Chart & Stats
$0.20
-$0.05(-20.00%)
At close: 4:00 PM EDT
$0.20
-$0.05(-20.00%)
Day’s Range― - ―
52-Week Range$0.18 - $0.27
Previous CloseN/A
Volume500.00
Average Volume (3M)0.00
Market Cap
$36.92M
Enterprise Value-$1.47
Total Cash (Recent Filing)$51.69M
Total Debt (Recent Filing)$1.52M
Price to Earnings (P/E)42.5
Beta0.31
Next Earnings
Feb 24, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield18%
Share Statistics
EPS (TTM)<0.01
Shares Outstanding180,591,800
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.44
Price to Book (P/B)0.50
Price to Sales (P/S)0.84
P/FCF Ratio3.06
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$0.26Price Target Upside29.63% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.01
Revenue Forecast (FY)$46.65M
Bulls Say, Bears Say
Bulls Say
Debt-free Balance Sheet And LiquidityA debt-free balance sheet and growing cash reserve provide financial resilience and funding flexibility. This supports continued product investment, reduces refinancing risk, and gives management capacity to execute its growth plan through weaker earnings periods.
Improved Operating And Free Cash GenerationStrong current operating and free cash flow indicates that the business is converting activity into cash despite weaker reported profitability. This can help fund product development internally and limits reliance on external capital, although consistency remains important.
Product Innovation And Strategic Enterprise AdoptionNew AI and service-based products broaden IR's monitoring proposition and create opportunities for recurring expansion. The major bank deployment provides a credible enterprise reference that may support discussions with other global financial institutions over time.
Bears Say
Revenue Contraction And Product-line ChurnBroad revenue declines across important product lines indicate that customer retention and expansion are not yet offsetting lost business. Persistent churn can weaken recurring revenue visibility, reduce operating leverage, and make future growth dependent on successful product migration.
Operating Loss And Near-term Margin PressureThe shift from EBITDA profit to loss shows that the current revenue base is not covering the company's operating structure. Planned increases in product investment may improve competitiveness later, but they extend the period of margin pressure and execution risk.
Weak Recurring Revenue MomentumFlat-to-declining subscription fees suggest that consumption-based growth has not yet accelerated, limiting the durability of the recurring revenue model. Without stronger renewals, adoption, and upsell, revenue visibility and the ability to absorb fixed costs remain constrained.
Integrated Research Limited News
IREHF FAQ
What was Integrated Research Limited’s price range in the past 12 months?
Integrated Research Limited lowest stock price was $0.18 and its highest was $0.27 in the past 12 months.
What is Integrated Research Limited’s market cap?
Integrated Research Limited’s market cap is $36.92M.
When is Integrated Research Limited’s upcoming earnings report date?
Integrated Research Limited’s upcoming earnings report date is Feb 24, 2027 which is in 163 days.
How were Integrated Research Limited’s earnings last quarter?
Integrated Research Limited released its earnings results on Aug 26, 2026. The company reported $0.011 earnings per share for the quarter.
Is Integrated Research Limited overvalued?
According to Wall Street analysts Integrated Research Limited’s price is currently Undervalued.
Does Integrated Research Limited pay dividends?
Integrated Research Limited pays a Notavailable dividend of $0.036 which represents an annual dividend yield of 18%. See more information on Integrated Research Limited dividends here
What is Integrated Research Limited’s EPS estimate?
Integrated Research Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Integrated Research Limited have?
Integrated Research Limited has 180,591,800 shares outstanding.
What happened to Integrated Research Limited’s price movement after its last earnings report?
Integrated Research Limited reported an EPS of $0.011 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Integrated Research Limited?
Currently, no hedge funds are holding shares in IREHF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Integrated Research Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$0.26 (29.63% Upside)
$0.26 (29.63% Upside)
Blogger Sentiment
Bullish
IREHF Sentiment 100%
Sector Average 61%
Sector Average 61%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-9.09%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.17%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Integrated Research Limited
Integrated Research Limited (IRI.AX), an Australian company founded in North Sydney in 1988, specializes in developing, deploying, and selling computer software for managing critical IT systems. Their solutions address business-critical computing, unified communication, and payment networks. The company's flagship product, Prognosis, is a comprehensive software suite engineered to provide management and technical teams with detailed operational insight into platforms such as HP NonStop, distributed system servers, unified communications environments, payment infrastructures, and core business applications. Beyond software, they also deliver testing, maintenance, and professional services, including a Software-as-a-Service (SaaS) option. Integrated Research operates globally, reaching clients in approximately 60 countries through direct sales offices in the United States, the United Kingdom, Germany, Singapore, and Australia, complemented by a broad international channel-driven distribution network. Their diverse customer base includes financial institutions like stock exchanges, banks, and credit card companies, alongside telecommunications carriers, service providers, and manufacturers.
IREHF Company Deck
IREHF Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture: meaningful near-term financial headwinds driven by a large one-off expected credit loss and continued churn in core product lines caused profitability to turn negative and pro forma revenue to decline. Offsetting this, IR has a strong cash position (no debt), improved operating cash flow, important product launches (Iris, Elevate), a significant deployment with a top-10 U.S. bank, and a clear product-led growth roadmap including an IR Labs MVP planned for calendar 2026. Management expects higher investment in H2 to fund growth. Overall, strategic product progress and balance-sheet strength are positives, while earnings, renewals volatility and near-term expense increases are material negatives — yielding a balanced outlook.View all IREHF earnings summariesIREHF Stock 12 Month Forecast
Average Price Target
$0.26
▲(29.63% Upside)
Technical Analysis
Hansen Technologies Limited
―
Connexion Telematics Limited
―
archTIS Ltd.
―
Prophecy International Holdings Ltd
―
Dubber Corporation Limited
―